Lmr Partners LLP Arbutus Biopharma Corp Transaction History
Lmr Partners LLP
- $10.9 Billion
- Q3 2024
A detailed history of Lmr Partners LLP transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Lmr Partners LLP holds 197,025 shares of ABUS stock, worth $658,063. This represents 0.01% of its overall portfolio holdings.
Number of Shares
197,025
Previous 255,401
22.86%
Holding current value
$658,063
Previous $789,000
3.93%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding ABUS
# of Institutions
156Shares Held
99.6MCall Options Held
2.31MPut Options Held
525K-
Morgan Stanley New York, NY21.7MShares$72.5 Million0.01% of portfolio
-
Whitefort Capital Management, LP New York, NY12.9MShares$43 Million26.34% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$38.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.92MShares$29.8 Million0.0% of portfolio
-
Two Seas Capital LP Rye, NY8.39MShares$28 Million10.86% of portfolio
About Arbutus Biopharma Corp
- Ticker ABUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 149,951,008
- Market Cap $501M
- Description
- Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...